Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use, 26-29 May 2009 29 Μάιος 2009Press releaseHuman BioPartners GmbH withdraws its application for Biferonex (interferon beta-1a) 29 Μάιος 2009Press release Committee for medicinal products for veterinary use: Meeting of 12-14 May 2009 15 Μάιος 2009Press releaseVeterinary Sepracor Pharmaceuticals Ltd withdraws its marketing authorisation application for Lunivia (eszopiclone) 15 Μάιος 2009Press release Committee for veterinary medicinal products: 43rd meeting 12 Μάιος 2009Press releaseVeterinary European Medicines Agency recommendations on extension of shelf life for Tamiflu 8 Μάιος 2009Press releaseHumanMedicines European Medicines Agency gives guidance for use of antiviral medicines in case of a novel influenza A/H1N1 pandemic 8 Μάιος 2009Press releaseHumanMedicines Meeting highlights from the Paediatric Committee: 28 - 30 April 2009 5 Μάιος 2009Press releaseHumanPaediatrics European Medicines Agency prepares for approval of pandemic vaccines 30 Απρίλιος 2009Press releaseMedicines EMEA-coordinated PROTECT project has been accepted for funding by the Innovative Medicines Initiative joint undertaking 29 Απρίλιος 2009Press releaseMedicines 1 … 303 304 305 306 307 Page 307 of 385 308 309 310 311 … 385
Meeting highlights from the Committee for Medicinal Products for Human Use, 26-29 May 2009 29 Μάιος 2009Press releaseHuman
BioPartners GmbH withdraws its application for Biferonex (interferon beta-1a) 29 Μάιος 2009Press release
Committee for medicinal products for veterinary use: Meeting of 12-14 May 2009 15 Μάιος 2009Press releaseVeterinary
Sepracor Pharmaceuticals Ltd withdraws its marketing authorisation application for Lunivia (eszopiclone) 15 Μάιος 2009Press release
European Medicines Agency recommendations on extension of shelf life for Tamiflu 8 Μάιος 2009Press releaseHumanMedicines
European Medicines Agency gives guidance for use of antiviral medicines in case of a novel influenza A/H1N1 pandemic 8 Μάιος 2009Press releaseHumanMedicines
Meeting highlights from the Paediatric Committee: 28 - 30 April 2009 5 Μάιος 2009Press releaseHumanPaediatrics
European Medicines Agency prepares for approval of pandemic vaccines 30 Απρίλιος 2009Press releaseMedicines
EMEA-coordinated PROTECT project has been accepted for funding by the Innovative Medicines Initiative joint undertaking 29 Απρίλιος 2009Press releaseMedicines